Affiliation:
1. Zhongnan Hospital of Wuhan University
Abstract
Abstract
Background
Transmembrane protein 88 (TMEM88) is a cancer-related protein that acts as a cancer-promoting or cancer-inhibiting regulator in multiple tumor types. However, the exact role of TMEM88 in liver cancer is unclear. This study was designed to determine the expression of TMEM88 in liver cancer cells.
Results
TMEM88 expression was higher in liver cancer tissues than in corresponding normal tissues. TMEM88 expression in HCC (Hepatocellular Carcinoma) tissues correlates with prognosis. Low TMEM88 expression was associated with poorer overall survival, disease-specific survival, progression-free survival, and relapse-free survival in multiple cohorts of patients with HCC, particularly in late disease stages (grades 2 and 3). Furthermore, there was a positive correlation among MCPCOUNTER infiltration, XCELL infiltration and TIDE infiltration of TMEM88 in liver tumor cells.
Conclusions
These findings demonstrate that TMEM88 is a protective gene in HCC and promotes immune escape.
Publisher
Research Square Platform LLC
Reference32 articles.
1. Global trends and predictions in hepatocellular carcinoma mortality;Bertuccio P;J Hepatol,2017
2. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang JD;Nat Rev Gastroenterol Hepatol,2019
3. Siegel RL, Miller KD, Fuchs HE and Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7–33.
4. Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases;Marrero JA;Hepatology,2018
5. Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma;Huang X;Aging (Albany NY),2022